Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A combined approach of medical treatments, natural remedies, diet, and stress management is best for hair regrowth in Cambodia.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

A new mouse model helps understand and find treatments for alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Researchers successfully used nude mice to study human hair growth, which could help with future hair research.

Platelet-rich plasma (PRP) helps regrow hair in male pattern baldness.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Minoxidil rejuvenates hair follicles and reduces aging signs in male pattern baldness.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Minoxidil and PRP can help convert miniaturized hair follicles back to normal in male pattern baldness.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Human hair follicle dermal cells can help repair damaged hair follicles.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Minoxidil solution and foam both increase hair growth, but the solution works better than the foam.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Talquetamab may cause hair loss and skin issues.

Apremilast did not work for treating severe alopecia areata.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.